Position in AVBP
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,745,953
+$2,053,554 QoQ
Shares Held
79,043
+163.4% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
1.92%
of 13F equity value
Holder Rank
#45
of 158 holders
Holding Since
Mar 2025
6 quarters on record
Voting authority
Sole 35%
Shared 0%
None 65%
Common Shares in AVBP Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026SECTORAL ASSET MANAGEMENT INC holds $69,797,747 across 47 Biotechnology names. AVBP ranks #7 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CTNM |
Contineum Therapeutics, Inc.
|
727,587 | $11,925,150 | |
| 2 | ORKA |
Oruka Therapeutics, Inc.
|
41,987 | $3,995,902 | |
| 3 | BNTX |
BioNTech SE
|
41,869 | $3,895,910 | |
| 4 | DFTX |
Definium Therapeutics, Inc.
|
78,310 | $3,683,702 | |
| 5 | RCUS |
Arcus Biosciences, Inc.
|
110,870 | $3,418,122 | |
| 6 | SMMT |
Summit Therapeutics Inc.
|
220,180 | $3,208,022 | |
| 7 | AVBP |
ArriVent BioPharma, Inc.
This page
|
79,043 | $2,745,953 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
5,432 | $2,698,237 |
All Filings in AVBP
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,745,953 | 79,043 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $692,399 | 30,013 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $769,690 | 38,255 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $723,885 | 39,235 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $774,576 | 35,580 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $186,564 | 10,090 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||